Preparation and characterization of marine sponge collagen nanoparticles and employment for the transdermal delivery of 17β-estradiol-hemihydrate

References

• Kreuter J. (1994). Drug targeting with nanoparticles. Eur J Drug Metab Pharmacokinet, 19(3):253–6.
   PubMed Web of Science ®Google Scholar
• Kreuter J. (1996). Nanoparticles and microparticles for drug and vaccine delivery. J Anat, 189(Pt 3):503–5.
   PubMed Web of Science ®Google Scholar
• Alonso MJ. (2004). Nanomedicines for overcoming biological barriers. Biomed Pharmacother, 58:168–72.
   PubMed Web of Science ®Google Scholar
• Liu Y, Lü WL, Zhang Q. (2006). Recent advanced in liposomes and nanoparticles as drug carriers for drug delivery. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 28(4):583–9.
   PubMedGoogle Scholar
• Friess W. (1998). Collagen—biomaterial for drug delivery. Eur J Pharm Biopharm, 45(2):113–36.
   PubMed Web of Science ®Google Scholar
• Kleinmann G, Larson S, Hunter B, Stevens S, Mamalis N, Olson RJ. (2007). Collagen shileds as a drug delivery system for fourth-generation fluoroquinolones. Ophthalmologica, 221(1):51–6.
   PubMed Web of Science ®Google Scholar
• Aishwarya S, Mahalakshmi S, Sehgal PK. (2008). Collagen-coated polycaprolactone microparticles as a controlled drug delivery system. J Microencapsul, 7:1–9.
   Google Scholar
• Takezawa T, Takeuchi T, Nitani A, Takayama Y, Kino-Oka M, Taya M, . (2007). Collagen vitrigel membrane useful for paracrine assays in vitro and drug delivery systems in vivo. J Biotechnol, 131(1):76–83.
   PubMed Web of Science ®Google Scholar
• Rössler B, Kreuter J, Ross G. (1994). Effect of collagen microparticles on the stability of retinol and its absorption into hairless mouse skin in vitro. Pharmazie, 49:175–9.
   PubMed Web of Science ®Google Scholar
• Swatschek D, Schatton W, Müller WEG, Kreuter J. (2002). Microparticles derived from marine sponge collagen (SCMPs): Preparation characterization and suitability for dermal delivery of all-trans Retinol. Eur J Pharm Biopharm, 54:125–33.
   PubMed Web of Science ®Google Scholar
• Swatschek D, Schatton W, Müller WEG, Kreuter J. (2000). Maritime sponge collagen: Isolation, characterization and suitability for microparticle-preparation. Arch Pharm Pharm Med Chem, 333(1):31.
   Google Scholar
• Swatschek D, Schatton W, Kellermann J, Müller WEG, Kreuter J. (2002). Marine sponge collagen: Isolation, characterization and effects on the skin parameters surface-pH, moisture and sebum. Eur J Pharm Biopharm, 53(1):107–13.
   PubMed Web of Science ®Google Scholar
• Garrone R, Huc A, Junqua S. (1975). Fine structure and physiocochemical studies on the collagen of the marine sponge Chondrosia reniformis Nardo. J Ultrastruct Res, 52(2):261–75.
   PubMedGoogle Scholar
• Heinemann S, Ehrlich H, Douglas T, Heinemann C, Worch H, Schatton W, . (2007). Ultrastructural studies on the collagen of the marine sponge Chondrosia reniformis Nardo. Biomacromolecules, 8(11):3452–7.
   PubMed Web of Science ®Google Scholar
• De Lignieres B, Basdevant A, Thomas G, Thalabard JC, Mercier-Bodard C, Conard J, . (1986). Biological effects of estradiol-17 beta in postmenopausal women: Oral versus transdermal administration. J Clin Endocrinol Metab, 62:536–41.
   PubMed Web of Science ®Google Scholar
• Scarabin PY, Alhenc-Gelas M, Plu-Bureau G, Taisne P, Agher R, Aiach M. (1997). Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. Arterioscler Thromb Vasc Biol, 17:3071–8.
   PubMed Web of Science ®Google Scholar
• Vehkavaara S, Silveira A, Hakala-Ala-Pietilä T, Virkamäki A, Hovatta O, Hamsten A, . (2001). Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women. Thromb Haemost, 85:619–25.
   PubMed Web of Science ®Google Scholar
• Vongpatanasin W, Tuncel M, Wang Z, Arbiyue D, Mehrad B, Jialal I. (2003). Differential effects of oral versus transdermal estrogen replacement therapy on C-reactive protein in postmenopausal women. J Am Coll Cardiol, 41:1358–63.
   PubMed Web of Science ®Google Scholar
• Schatton W, Schatton M, Swatschek D, Müller WEG, Kreuter J. (2007) .Method for isolating collagen from marine sponges and producing nanoparticulate collagen, and the use thereof. European Patent no. 1 259 120 B1, 35.
   Google Scholar
• Horcas I, Fernandez R, Gomez-Rodriguez JM, Colchero J, Gomez-Herrero J, Baro AM. (2007). WSXM: A software for scanning probe microscopy and a tool for nanotechnology. Rev Sci Instrum, 78(1):013705-1–013705-8. 2007
   Google Scholar
• European Pharmacopoeia. (2005). 5th ed., monograph 0821. Stuttgart: Deutscher Apotheker Verlag, 2087–8.
   Google Scholar
• Kivlighan KT, Granger DA, Schwartz EB. (2005). Blood contamination and the measurement of salivary progesterone and estradiol. Horm Behav, 47(3):367–70.
   PubMed Web of Science ®Google Scholar
• Kirschbaum C, Read GF, Hellhammer DH. (1992). Assessment of hormones and drugs in saliva in biobehavioral research, Seattle, Toronto, Bern, Göttingen: Hogrefe & Huber.
   Google Scholar
• Lu Y, Bentley GR, Gann PH, Hodges KR, Chatterton RT. (1999). Salivary estradiol and progesterone levels in conception and nonconception cycles in women: Evaluation of a new assay for salivary estradiol. Fertil Steril, 71:863–8.
   PubMed Web of Science ®Google Scholar
• Malamud D, Tabak L, eds. (1993). Saliva as a diagnostic fluid. Ann NY Acad Sci, 694:1–348.
   Google Scholar
• Worthman CM, Stalling JF, Hofman LF. (1990). Sensitive salivary estradiol assay for monitoring ovarian function. Clin Chem, 36:1769–73.
   PubMed Web of Science ®Google Scholar
• Rössler B, Kreuter J, Scherer D. (1995). Collagen microparticles: preparation and properties. J Microencapsul, 12:49–57.
   PubMed Web of Science ®Google Scholar
• Berthold A, Cremer K, Kreuter J. (1998). Collagen microparticles: Carriers for glucocorticoids. Eur J Pharm Biopharm, 45:23–9.
   PubMed Web of Science ®Google Scholar
• Blacker C, Brion N, Caulin F, Mayolle C, Reginster JY, Regnard A, . (1996). Plasma concentration of estradiol after transdermal administration of Systen® 50 (Evorel®) or Menorest®. Clin Drug Invest, 11:339–46.
   Web of Science ®Google Scholar
• Järvinen A, Bäckström A-C, Elfström C, Viitanen A. (2001). Comparative absorption and variability in absorption of estradiol from a transdermal gel and a novel matrix-type transdermal patch. Maturitas, 38:189–96.
   PubMed Web of Science ®Google Scholar